previous compound ID: 2198 next compound
InChIKey: UEJJHQNACJXSKW-UHFFFAOYSA-N
SMILES: C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "JW Hanrahan" "J Liao" "DY Thomas" "SD Macknight" "D Rotin" "J Goepp" "E Matthes" "B Kus" "R Robert"

chemical graph of compound 2198





CID is 5426
synonyms found at PubChem are:
thalidomide, 50-35-1, Thalomid, Sedoval, (+/-)-THALIDOMIDE, 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, Corronarobetin, Psycholiquid, Psychotablets, Theophilcholine, Algosediv, Asmadion, Bonbrain, Calmorex, Contergan, Distaval, Ectiluran, Enterosediv, Gastrinide, Glutanon, Hippuzon, Neosedyn, Neosydyn, Nerosedyn, Neufatin, Neurodyn, Neurosedin, Neurosedym, Nevrodyn, Noctosediv, Pantosediv, Polygripan, Profarmil, Quetimid, Quietoplex, Sandormin, Sedimide, Sedisperil, Shinnibrol, Softenil, Softenon, Talargan, Talismol, Telargean, Tensival, Thalinette, Valgraine, Asmaval, Calmore, Glupan, Grippex, Imidene, Isomin, Kevadon, Nibrol, Noxodyn, Pangul, Sleepan, Slipro, Talimol, Telagan, Thalin, Valgis, Yodomin, N-Phthaloylglutamimide, Sedin, Predni-Sediv, Imida-lab, Poly-Giron, Sedalis sedi-lab, Shin-naito S, Neaufatin, Asidon 3, Pro-ban M, Imidan (peyta), N-Phthalylglutamic acid imide, Talidomida, 3-Phthalimidoglutarimide, alpha-Phthalimidoglutarimide, Thalidomidum, Bonbrrin, Distaxal, Distoval, Thalomide, Kedavon, (+-)-Thalidomide, K-17, 2,6-Dioxo-3-phthalimidopiperidine, N-Phthalyl-glutaminsaeure-imid, Thalidomide Celgene, Pro-Bam M, Talidomide [DCIT], alpha-N-Phthalylglutaramide, Neurosedyn, Sedalis, Talidomide, Telargan, N-(2,6-Dioxo-3-piperidyl)phthalimide, Glutarimide, 2-phthalimido-, NSC-66847, alpha-(N-Phthalimido)glutarimide, Talidomida [INN-Spanish], Thalidomidum [INN-Latin], Thalidomine USP26, K 17, E-217, Synovir, Talizer, Thaled, ENMD 0995, 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline, Thalomid (TM), Thalomid (TN), Thalidomide Pharmion, .alpha.-N-Phthalylglutaramide, Thaled (TN), N-Phthalyl-glutaminsaeure-imid [German], Thalidomide [USAN:INN:BAN], N-Phthalimidoglutamic acid imide, 2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione, HSDB 3586, Phthalimide, N-(2,6-dioxo-3-piperidyl)-, C13H10N2O4, EINECS 200-031-1, IN1061, CHEMBL468, Thalidomide (soluble form), NSC 527179, BRN 0030233, .alpha.-Phthalimidoglutarimide, Thalidomide (JAN/USP/INN), AI3-50606, 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione, 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione, (+-)-N-(2,6-Dioxo-3-piperidyl)phthalimide, CHEBI:74947, UEJJHQNACJXSKW-UHFFFAOYSA-N, .alpha.-(N-Phthalimido)glutarimide, NSC66847, THALIDOMIDE (AIDS INITIATIVE), N-(2,6-dioxo-3-piperidinyl)phthalimide, NCGC00015989-09, DSSTox_CID_2524, DSSTox_RID_76611, (+/-)-N-(2,6-Dioxo-3-piperidinyl)phthalimide, DSSTox_GSID_22524, 2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione, 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione, 2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione, (?)-Thalidomide, Phthalimide,6-dioxo-3-piperidyl)-, (+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione, 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (+-)-, WLN: T56 BVNVJ C- DT6VMVTJ, 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, SR-01000076184, Thalidomide (+ and -), Celgene, Pharmion, Talinol, CCRIS 8148, (y)-Thalidomide, Thalidomide,(S), CAS-50-35-1, Prestwick_463, Thalomid, Thalidomide, Thalidomide [USAN:USP:INN:BAN:JAN], (A+/-)-Thalidomide, Thalidomide (+ and-), AC1L1KBZ, AC1Q6FJA, Prestwick0_000192, Prestwick1_000192, Prestwick2_000192, Prestwick3_000192, Spectrum2_000707, Spectrum3_001715, Spectrum4_001087, Spectrum5_001791, (.+/-.)-Thalidomide, D0U7GK, UPCMLD-DP139, Thalomid (TN) (Celgene), SCHEMBL7581, Celgene Brand of Thalidomide, NCIOpen2_003188, Lopac0_001224, BSPBio_000143, BSPBio_001156, BSPBio_003330, KBioGR_000496, KBioGR_001474, KBioGR_002322, KBioSS_000496, KBioSS_002324, MLS000069353, ARONIS24496, DivK1c_000051, SPECTRUM1503607, SPBio_000893, SPBio_002064, BPBio1_000159, GTPL7327, DTXSID9022524, SCHEMBL15197560, UPCMLD-DP139:001, CTK8B6291, HMS500C13, KBio1_000051, KBio2_000496, KBio2_002322, KBio2_003064, KBio2_004890, KBio2_005632, KBio2_007458, KBio3_000911, KBio3_000912, KBio3_002550, KBio3_002802, cMAP_000022, MolPort-003-665-582, NINDS_000051, Bio1_000387, Bio1_000876, Bio1_001365, Bio2_000418, Bio2_000898, HMS1362J17, HMS1568H05, HMS1792J17, HMS1922E12, HMS1990J17, HMS2090O05, HMS2093G15, HMS2095H05, HMS2234C07, HMS3259C22, HMS3263F10, HMS3266F13, HMS3373E06, HMS3373G15, HMS3403J17, HMS3654A20, HMS3712H05, Pharmakon1600-01503607, BCP19772, NSC91729, NSC91730, (inverted question mark)-Thalidomide, Tox21_110275, Tox21_300580, Tox21_501224, AC-917, ANW-53225, BBL023439, BDBM50070114, CCG-39878, LS-140, MFCD00153873, NSC-91729, NSC-91730, NSC527179, NSC758479, STL356025, ( inverted question mark)-Thalidomide, AKOS009529198, Tox21_110275_1, CS-1084, DB01041, LP01224, MCULE-6327754946, NC00600, NSC-527179, NSC-758479, RP29207, (+/-)-Thalidomide, >=98%, powder, IDI1_000051, IDI1_002173, KS-00000H64, n-(2,6-dioxopiperidin-3-yl)phthalimide, NCGC00015989-03, NCGC00015989-04, NCGC00015989-05, NCGC00015989-06, NCGC00015989-07, NCGC00015989-08, NCGC00015989-10, NCGC00015989-11, NCGC00015989-12, NCGC00015989-13, NCGC00015989-14, NCGC00015989-16, NCGC00015989-17, NCGC00024708-02, NCGC00024708-03, NCGC00024708-04, NCGC00024708-05, NCGC00024708-06, NCGC00024708-07, NCGC00024708-08, NCGC00024708-09, NCGC00024708-10, NCGC00024708-11, NCGC00254343-01, NCGC00261909-01, 731-40-8, AN-15419, AS-12367, BC204656, CPD000058524, HY-14658, KB-61574, NCI60_023904, SAM002564245, SC-18573, SMR000058524, WLN: T56 BVNVJ C- DT6VMVTJ -D, WLN: T56 BVNVJ C- DT6VMVTJ -L, SBI-0051191.P003, AB0011813, AB2000009, LS-109463, Phthalimide,6-dioxo-3-piperidyl)-, (+)-, Phthalimide,6-dioxo-3-piperidyl)-, (-)-, TC-141970, AB00052362, EU-0101224, FT-0600001, FT-0631211, S1193, ST24027458, ST51039042, Phthalimide,6-dioxo-3-piperidyl)-, D-(+)-, Phthalimide,6-dioxo-3-piperidyl)-, L-(-)-, (+/-)-N-(2,6-dioxo-3-piperidyl)phthalimide, C07910, D00754, J90042, M-1523, AB00052362-11, AB00052362-12, AB00052362-13, AB00052362_14, AB00052362_15, 153T873, I06-0197, SR-01000076184-1, SR-01000076184-3, SR-01000076184-5, SR-01000076184-8, W-105969, BRD-A93255169-001-04-4, BRD-A93255169-001-06-9, BRD-A93255169-001-24-2, I14-23643, Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)-, Z1550675451, 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)-, 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)-, 2-(2,6-dioxoazaperhydroin-3-yl)benzo[c]azoline-1,3-dione, 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione #, [(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione, Thalidomide, United States Pharmacopeia (USP) Reference Standard, ( inverted question mark)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione, 2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione, 1012310-87-0, 14088-68-7